1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with cloricromen in 3 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (cloricromen) | Trials (cloricromen) | Recent Studies (post-2010) (cloricromen) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 71 | 3 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dejana, E; Prosdocimi, M; Zanetti, A; Zatta, A | 1 |
de Gaetano, G; Dejana, E; Finesso, M; Gorio, A; Languino, LR; Prosdocimi, M; Tessari, F | 1 |
Francescangeli, E; Goracci, G; Gresele, P; Mezzasoma, AM; Nenci, GG; Prosdocimi, M; Ribaldi, E | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cloricromen
Article | Year |
---|---|
The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Aspirin; beta-Thromboglobulin; Blood Platelets; Chromonar; Coumarins; Drug Interactions; Epinephrine; Humans; In Vitro Techniques; Masoprocol; Platelet Activating Factor; Platelet Aggregation; Pyrazoles | 1986 |
Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Chromonar; Collagen; Coronary Disease; Coumarins; Disease Models, Animal; Dogs; Epinephrine; Male; Platelet Activating Factor; Platelet Aggregation; Regional Blood Flow; Thromboxane B2 | 1985 |
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.
Topics: Acetyltransferases; Calcimycin; Chromonar; Diacylglycerol Cholinephosphotransferase; Enzyme Activation; Humans; In Vitro Techniques; Indicators and Reagents; Ionophores; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation Inhibitors | 1996 |